Aehr Test Systems (AEHR) EBITDA Margin (2010 - 2026)

Aehr Test Systems (AEHR) has reported EBITDA Margin for 16 consecutive years, with 6.4% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA Margin rose 1634.0% year-over-year to 6.4%; the trailing twelve-month figure through May 2026 stood at 28.3% (down 1867.0% YoY), and the FY2026 full-year result was 28.3%, down 1867.0% from the prior year.
• EBITDA Margin rose to 6.4% in Q2 2026 per AEHR's latest filing, from 41.01% in the prior quarter.
• Across five years, EBITDA Margin topped out at 28.69% in Q2 2022 and bottomed at 47.03% in Q4 2025.
• Historically, EBITDA Margin has averaged 1.0% across 5 years, with a median of 2.75% in 2022.
• The sharpest annual moves came in 2022 and 2024: EBITDA Margin jumped 2714 bps in 2022, then sank 4910 bps in 2024.
• Over 5 years, EBITDA Margin stood at 23.52% in 2022, then advanced by 8 bps to 25.51% in 2023, then tumbled by 144 bps to 11.25% in 2024, then slumped by 318 bps to 47.03% in 2025, then jumped by 86 bps to 6.4% in 2026.
• According to Business Quant data, EBITDA Margin over the past three periods registered 6.4%, 41.01%, and 47.03% for Q2 2026, Q1 2026, and Q4 2025 respectively.